A. Sasser
New England Journal of Medicine · 2009–2016
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from A. Sasser's perspective
Ordered by how strongly the researchers A. Sasser trusts endorse each paper. Same corpus, a different order for every researcher.
- Fibroblasts in cancer (Nature Reviews. Cancer)
- Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. (Journal of the National Cancer Institute)
- Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. (Blood)
- Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. (Cancer Research)
- Tensional homeostasis and the malignant phenotype. (Cancer Cell)
- Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model (Gene Therapy)
- Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. (Cancer Research)
- Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro (Stem Cells)
- Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma (Journal of Experimental Medicine)
- Mesenchymal stem cells within tumour stroma promote breast cancer metastasis (Nature)
Their papers
- Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression (2009) — 810 citations
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. (2016) — 881 citations
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma. (2015) — 1,029 citations
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells (2009) — 755 citations